⌕
PTC Therapeutics · PTCT · Nasdaq
Tenet 74 · Solid
Compare
$63.49+0.21%At closeTenet 74 · Solid
$63.49+0.13 (+0.21%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

PTC Therapeutics (PTCT) Stock

PTC Therapeutics (PTCT) closed at $63.49 on Nov 13, 2026; its Tenet Score is 74 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

23 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$63.49
Nov 13, 2026
Market cap
$5.3B
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
58.80 – 90.87
low → high
Tenet Score
74/100
Solid · 409 Healthcare peers

Industry: Drugs · see every company filed here →

PTC Therapeutics Inc scores 74/100. Solid. Strongest on value and growth versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
74/ 100
Solid
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
96
Quality
55
Health
55
Growth
90

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueAQualityCHealthCGrowthAMomentumF
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
loss
P/B
—
neg_equity
P/S
5.3×
price to fiscal 2025 sales
ROE
—
neg_equity
Operating margin
50.1%
fiscal 2025, before interest and tax
Net margin
−3.8%
of revenue kept
Current ratio
3.39
current assets to liabilities
Net debt / EBITDA
−10.1×
leverage, net of cash
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About PTC Therapeutics Inc

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of d…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 127 US ETFs · top wrappers by weightSee all ETFs holding PTCT →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is PTC Therapeutics in?

PTC Therapeutics is in the Healthcare sector and the Drugs industry.

What is PTC Therapeutics' Tenet Score?

PTC Therapeutics' Tenet Score is 74 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.